Pointner R, Conrad F, Schwab G
II. Universitätsklinik für Chirurgie, Innsbruck.
Wien Klin Wochenschr. 1989 Jul 14;101(14):482-4.
Expectations of early diagnosis of carcinoma of the stomach and pancreas by using the tumour markers CEA and CA 19-9 have been disappointed. Although the sensitivity of CA 19-9 for pancreatic cancer is high, its field of application for screening is not efficient due to poor specificity of the marker. CEA and CA 19-9 are of great importance in the follow-up of pancreatic cancer. Results of tests of CEA and CA 19-9 in 100 patients with gastric cancer and 50 patients suffering from pancreatic cancer are reported.
通过使用肿瘤标志物癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)来实现胃癌和胰腺癌早期诊断的期望已落空。尽管CA 19-9对胰腺癌的敏感性较高,但由于该标志物特异性较差,其在筛查中的应用效率不高。CEA和CA 19-9在胰腺癌的随访中具有重要意义。本文报告了100例胃癌患者和50例胰腺癌患者的CEA和CA 19-9检测结果。